AzTrials
AzTrials

Carpal Tunnel SyndromePhase 1/2NCT00929123

Mechanisms of Neural Mobilization in the Treatment of Chronic Pain

A Phase 1/2 study testing neural mobilization in people with Carpal Tunnel Syndrome, run by University of Florida at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study was to determine the effect of a manual therapy technique (neural mobilization) on measures of clinical pain and function, experimental pain sensitivity, and on the function of the median nerve in individuals with carpal tunnel syndrome. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Carpal Tunnel Syndrome
What is being tested?
neural mobilization
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
40 participants
Where
1 siteUnited States
Study dates
May 2007to Jun 2009
Phase
Phase 1/2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 18 to 70 years of age
  • signs and symptoms of carpal tunnel syndrome for greater than 12 weeks

Who cannot join

  • non english speaking
  • prior surgery for carpal tunnel syndrome
  • systemic condition known to affect sensation
  • chronic pain condition other than carpal tunnel syndrome

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Florida

    Gainesville, Florida, 32611

Other trials in United States

About this study

The purpose of this study was to determine the effect of a manual therapy technique (neural mobilization) on measures of clinical pain and function, experimental pain sensitivity, and on the function of the median nerve in individuals with carpal tunnel syndrome. The investigators hypothesized that individuals receiving a neural mobilization technique known to directly stress the median nerve would demonstrate greater improvements in clinical pain and function, experimental pain sensitivity, and median nerve function than those receiving a sham technique.

Being tested
neural mobilization, sham neural mobilization, healthy controls
Keywords
manual therapy, carpal tunnel syndrome, central sensitization
Medical subject headings
Carpal Tunnel Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • neural mobilizationProcedure or surgery

    Also called upper limb tension test with median nerve bias

    manual therapy technique known to directly stress the median nerve

  • sham neural mobilizationProcedure or surgery

    sham technique mimicking the neural mobilization which is not specific to the median nerve

  • healthy controlsOther

    People without carpal tunnel syndrome for comparison

Study groups in NCT00929123
Study groupRoleWhat they receive
neural mobilizationExperimentalmanual therapy technique known to directly stress the median nerve
Receives: Procedure: neural mobilization
sham neural mobilizationPlacebo comparatormanual therapy technique known to directly stress the median nerve without any stimulation.
Receives: Procedure: sham neural mobilization
Healthy ControlsActive comparatorPeople without carpal tunnel syndrome for comparison
Receives: Other: healthy controls

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. thermal and pressure pain sensitivity

    Measured: immediate effect

Secondary outcomes (5)
  1. grip strength

    Measured: 3 weeks

  2. wrist range of motion

    Measured: 3 weeks

  3. clinical pain

    Measured: 3 weeks

  4. self report of disability

    Measured: 3 weeks

  5. median nerve function

    Measured: 3 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jun 2009 (estimated)
  2. Study startMay 2007
  3. Primary completionJul 2008
  4. Study completionJun 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00929123
Sponsor's protocol ID
R21AT002796
Other IDs
R21AT002796, R21AT002796-01A1
Status last verified
Mar 2015
First submitted
25 Jun 2009
Last updated
17 Mar 2015
Results posted
No
Data monitoring committee
No

Publications

  • Bialosky JE, Bishop MD, Price DD, Robinson ME, Vincent KR, George SZ. A randomized sham-controlled trial of a neurodynamic technique in the treatment of carpal tunnel syndrome. J Orthop Sports Phys Ther. 2009 Oct;39(10):709-23. doi: 10.2519/jospt.2009.3117.

    PubMed 19801812
  • Bialosky JE, Bishop MD, Robinson ME, Price DD, George SZ. Heightened pain sensitivity in individuals with signs and symptoms of carpal tunnel syndrome and the relationship to clinical outcomes following a manual therapy intervention. Man Ther. 2011 Dec;16(6):602-8. doi: 10.1016/j.math.2011.06.003. Epub 2011 Jul 20.

    PubMed 21764354
  • Bialosky JE, Bishop MD, Price DD, Robinson ME, George SZ. The mechanisms of manual therapy in the treatment of musculoskeletal pain: a comprehensive model. Man Ther. 2009 Oct;14(5):531-8. doi: 10.1016/j.math.2008.09.001. Epub 2008 Nov 21.

    PubMed 19027342

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing neural mobilization in people with Carpal Tunnel Syndrome, run by University of Florida at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Mar 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

thermal and pressure pain sensitivity (time frame: immediate effect). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00929123, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Mar 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in